Case Report | ||||||||||||||||||||||||||||||||
Open Vet J. 2022; 12(4): 511-518 Use of the SGLT2 inhibitor canagliflozin for control of refractory equine hyperinsulinemia and laminitis Eleanor Marie Kellon, Kathleen M Gustafson.
|
How to Cite this Article |
Pubmed Style Kellon EM, Gustafson KM. Use of the SGLT2 inhibitor canagliflozin for control of refractory equine hyperinsulinemia and laminitis. Open Vet J. 2022; 12(4): 511-518. doi:10.5455/OVJ.2022.v12.i4.14 Web Style Kellon EM, Gustafson KM. Use of the SGLT2 inhibitor canagliflozin for control of refractory equine hyperinsulinemia and laminitis. https://www.openveterinaryjournal.com/?mno=103770 [Access: October 10, 2024]. doi:10.5455/OVJ.2022.v12.i4.14 AMA (American Medical Association) Style Kellon EM, Gustafson KM. Use of the SGLT2 inhibitor canagliflozin for control of refractory equine hyperinsulinemia and laminitis. Open Vet J. 2022; 12(4): 511-518. doi:10.5455/OVJ.2022.v12.i4.14 Vancouver/ICMJE Style Kellon EM, Gustafson KM. Use of the SGLT2 inhibitor canagliflozin for control of refractory equine hyperinsulinemia and laminitis. Open Vet J. (2022), [cited October 10, 2024]; 12(4): 511-518. doi:10.5455/OVJ.2022.v12.i4.14 Harvard Style Kellon, E. M. & Gustafson, . K. M. (2022) Use of the SGLT2 inhibitor canagliflozin for control of refractory equine hyperinsulinemia and laminitis. Open Vet J, 12 (4), 511-518. doi:10.5455/OVJ.2022.v12.i4.14 Turabian Style Kellon, Eleanor Marie, and Kathleen M Gustafson. 2022. Use of the SGLT2 inhibitor canagliflozin for control of refractory equine hyperinsulinemia and laminitis. Open Veterinary Journal, 12 (4), 511-518. doi:10.5455/OVJ.2022.v12.i4.14 Chicago Style Kellon, Eleanor Marie, and Kathleen M Gustafson. "Use of the SGLT2 inhibitor canagliflozin for control of refractory equine hyperinsulinemia and laminitis." Open Veterinary Journal 12 (2022), 511-518. doi:10.5455/OVJ.2022.v12.i4.14 MLA (The Modern Language Association) Style Kellon, Eleanor Marie, and Kathleen M Gustafson. "Use of the SGLT2 inhibitor canagliflozin for control of refractory equine hyperinsulinemia and laminitis." Open Veterinary Journal 12.4 (2022), 511-518. Print. doi:10.5455/OVJ.2022.v12.i4.14 APA (American Psychological Association) Style Kellon, E. M. & Gustafson, . K. M. (2022) Use of the SGLT2 inhibitor canagliflozin for control of refractory equine hyperinsulinemia and laminitis. Open Veterinary Journal, 12 (4), 511-518. doi:10.5455/OVJ.2022.v12.i4.14 |